{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:50:57Z","timestamp":1792497057343,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Triglyceride glucose-body mass index (TyG-BMI) and hemoglobin glycation index (HGI) are well-established surrogate markers for insulin resistance. Nevertheless, the extent to which these markers offer additive predictive value for heart failure (HF) prevalence in hypertensive populations, and their predictive utility across various diabetic statuses, remains to be clarified. Consequently, this study aimed to explore the independent and synergistic effects of TyG-BMI and HGI on HF risk among individuals with different diabetic statuses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from the study population (<jats:italic>n<\/jats:italic>\u2009=\u20099847) were obtained from the National Health and Nutrition Examination Survey (NHANES). Multivariable logistic regression models were employed to estimate odds ratios (ORs) and 95% confidence intervals (CIs) to assess the combined associations between TyG-BMI and HGI and the prevalence of HF across various diabetic statuses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the total population, compared to the reference group (low TyG-BMI and low HGI), the OR (95% CI) for HF prevalence was 1.30 (1.04, 1.64) for the combination of low TyG-BMI and high HGI, 2.40 (1.76, 3.29) for high TyG-BMI and low HGI, and 3.47 (2.41, 4.99) for high TyG-BMI and high HGI. Interestingly, among normoglycemic individuals, higher TyG-BMI and HGI did not significantly increase the prevalence of HF. Conversely, in the prediabetic population, the OR (95%CI) for HF prevalence was 2.42 (1.69, 3.48) for the combination of high TyG-BMI and low HGI, and 4.30 (2.45, 7.54) for high TyG-BMI and high HGI. Similarly, in the diabetic population, the OR (95%CI) for HF prevalence was 2.22 (1.43, 3.45) for low TyG-BMI and high HGI, 4.04 (2.43, 6.73) for high TyG-BMI and low HGI, and 4.13 (2.25, 7.59) for high TyG-BMI and high HGI, compared to low TyG-BMI and low HGI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study reveals that elevated TyG-BMI and HGI levels exert a synergistic impact on the prevalence of HF in hypertensive adults, especially in those with prediabetes and diabetes. Additionally, the presence of prediabetes and diabetes may amplify the detrimental combined effect of TyG-BMI and HGI on HF prevalence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-024-02045-9","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T08:04:43Z","timestamp":1708589083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Association of triglyceride glucose-body mass index and hemoglobin glycation index with heart failure prevalence in hypertensive populations: a study across different glucose metabolism status"],"prefix":"10.1186","volume":"23","author":[{"given":"Rupeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zening","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"issue":"17","key":"2045_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2022","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovascular Res. 2022;118(17):3272\u201387.","journal-title":"Cardiovascular Res"},{"issue":"1","key":"2045_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1(1):4\u201325.","journal-title":"ESC Heart Fail"},{"issue":"suppl1","key":"2045_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/diacare.26.2007.S80","volume":"26","author":"AD Association","year":"2003","unstructured":"Association AD. Treatment of hypertension in adults with diabetes. Diabetes Care. 2003;26(suppl1):80\u2013s82.","journal-title":"Diabetes Care"},{"issue":"9841","key":"2045_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","volume":"380","author":"E Ferrannini","year":"2012","unstructured":"Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380(9841):601\u201310.","journal-title":"Lancet"},{"issue":"5","key":"2045_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and Cardiovascular Disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575\u201384.","journal-title":"Can J Cardiol"},{"issue":"3","key":"2045_CR6","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride glucose-body Mass Index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.","journal-title":"PLoS ONE"},{"issue":"6","key":"2045_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2337\/dc14-1844","volume":"38","author":"JM Hempe","year":"2015","unstructured":"Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 2015;38(6):1067\u201374.","journal-title":"Diabetes Care"},{"issue":"1","key":"2045_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2045_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12944-021-01594-7","volume":"20","author":"C Jiang","year":"2021","unstructured":"Jiang C, Yang R, Kuang M, Yu M, Zhong M, Zou Y. Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes. Lipids Health Dis. 2021;20(1):161.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2045_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/met.2020.0092","volume":"19","author":"TH Raimi","year":"2021","unstructured":"Raimi TH, Dele-Ojo BF, Dada SA, Fadare JO, Ajayi DD, Ajayi EA, Ajayi OA. Triglyceride-glucose index and related parameters predicted metabolic syndrome in nigerians. Metab Syndr Relat Disord. 2021;19(2):76\u201382.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2045_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","volume":"22","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2045_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1399-5448.2009.00630.x","volume":"11","author":"AA Soros","year":"2010","unstructured":"Soros AA, Chalew SA, McCarter RJ, Shepard R, Hempe JM. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010;11(7):455\u201361.","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"2045_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2337\/diacare.27.10.2569","volume":"27","author":"PJ Twomey","year":"2004","unstructured":"Twomey PJ, Viljoen A, Reynolds TM, Wierzbicki AS. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004;27(10):2569\u201370.","journal-title":"Diabetes Care"},{"issue":"1","key":"2045_CR14","doi-asserted-by":"publisher","first-page":"107760","DOI":"10.1016\/j.jdiacomp.2020.107760","volume":"35","author":"W Kim","year":"2021","unstructured":"Kim W, Go T, Kang DR, Lee EJ, Huh JH. Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: a 10-year longitudinal cohort study. J Diabetes Complications. 2021;35(1):107760.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"2045_CR15","doi-asserted-by":"publisher","first-page":"e0175547","DOI":"10.1371\/journal.pone.0175547","volume":"12","author":"MA Marini","year":"2017","unstructured":"Marini MA, Fiorentino TV, Succurro E, Pedace E, Andreozzi F, Sciacqua A, Perticone F, Sesti G. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS ONE. 2017;12(4):e0175547.","journal-title":"PLoS ONE"},{"issue":"2","key":"2045_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","volume":"117","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovascular Res. 2021;117(2):423\u201334.","journal-title":"Cardiovascular Res"},{"issue":"3","key":"2045_CR17","first-page":"364","volume":"6","author":"D Banerjee","year":"2013","unstructured":"Banerjee D, Biggs ML, Mercer L, Mukamal K, Kaplan R, Barzilay J, Kuller L, Kizer JR, Djousse L, Tracy R. Insulin resistance and risk of incident heart failure: Cardiovascular Health Study. Circulation: Heart Fail. 2013;6(3):364\u201370.","journal-title":"Circulation: Heart Fail"},{"issue":"2","key":"2045_CR18","first-page":"105","volume":"10","author":"S Kishi","year":"2017","unstructured":"Kishi S, Gidding SS, Reis JP, Colangelo LA, Venkatesh BA, Armstrong AC, Isogawa A, Lewis CE, Wu C, Jacobs DR. Association of insulin resistance and glycemic metabolic abnormalities with LV structure and function in middle age: the CARDIA study. JACC: Cardiovasc Imaging. 2017;10(2):105\u201314.","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"4","key":"2045_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","volume":"116","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116(4):434\u201348.","journal-title":"Circulation"},{"issue":"4","key":"2045_CR20","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","volume":"101","author":"J Ren","year":"2021","unstructured":"Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745\u2013807.","journal-title":"Physiol Rev"},{"key":"2045_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40618-020-01288-4","volume":"44","author":"Y Yu","year":"2021","unstructured":"Yu Y, Hu L, Huang X, Zhou W, Bao H, Cheng X. BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation. J Endocrinol Investig. 2021;44:173\u201381.","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"2045_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"2045_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, et al. 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):19\u2013s40.","journal-title":"Diabetes Care"},{"issue":"1","key":"2045_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-022-03678-z","volume":"20","author":"Y Yu","year":"2022","unstructured":"Yu Y, Gu M, Huang H, Cheng S, Deng Y, Cai C, Chen X, Niu H, Ning X, Hua W. Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population. J Translational Med. 2022;20(1):1\u201312.","journal-title":"J Translational Med"},{"issue":"6","key":"2045_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/met.2018.0122","volume":"17","author":"C Bala","year":"2019","unstructured":"Bala C, Gheorghe-Fronea O, Pop D, Pop C, Caloian B, Comsa H, Bozan C, Matei C, Dorobantu M. The Association between six surrogate insulin resistance indexes and hypertension: a Population-based study. Metab Syndr Relat Disord. 2019;17(6):328\u201333.","journal-title":"Metab Syndr Relat Disord"},{"key":"2045_CR26","doi-asserted-by":"crossref","unstructured":"Gu Q, Hu X, Meng J, Ge J, Wang SJ, Liu XZ. Associations of Triglyceride-Glucose Index and Its Derivatives with Hyperuricemia Risk: A Cohort Study in Chinese General Population. Int J Endocrinol 2020, 2020:3214716.","DOI":"10.1155\/2020\/3214716"},{"issue":"11","key":"2045_CR27","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/jdi.13573","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, You A, Tomlinson B, Yue L, Zhao K, Fan H, Zheng L. Insulin resistance surrogates predict hypertension plus hyperuricemia. J Diabetes Investig. 2021;12(11):2046\u201353.","journal-title":"J Diabetes Investig"},{"issue":"7","key":"2045_CR28","doi-asserted-by":"publisher","first-page":"E550","DOI":"10.1152\/ajpendo.00384.2015","volume":"310","author":"A Burgeiro","year":"2016","unstructured":"Burgeiro A, Fuhrmann A, Cherian S, Espinoza D, Jarak I, Carvalho RA, Loureiro M, Patr\u00edcio M, Antunes M, Carvalho E. Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes. Am J physiology-endocrinology Metabolism. 2016;310(7):E550\u201364.","journal-title":"Am J physiology-endocrinology Metabolism"},{"issue":"5","key":"2045_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bpobgyn.2013.02.007","volume":"27","author":"G Bano","year":"2013","unstructured":"Bano G. Glucose homeostasis, obesity and diabetes. Best Pract Res Clin Obstet Gynecol. 2013;27(5):715\u201326.","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"issue":"4","key":"2045_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.trsl.2012.01.009","volume":"159","author":"TJ Lyons","year":"2012","unstructured":"Lyons TJ, Basu A. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Translational Res. 2012;159(4):303\u201312.","journal-title":"Translational Res"},{"issue":"8","key":"2045_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/dc08-0545","volume":"31","author":"DM Nathan","year":"2008","unstructured":"Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"2045_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1262-3636(07)70244-6","volume":"32","author":"G Delpierre","year":"2006","unstructured":"Delpierre G, Veiga-da-Cunha M, Vertommen D, Buysschaert M, Van Schaftingen E. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab. 2006;32(1):31\u20139.","journal-title":"Diabetes Metab"},{"issue":"11\u201312","key":"2045_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1159\/000517462","volume":"106","author":"V Gonzalez-Covarrubias","year":"2021","unstructured":"Gonzalez-Covarrubias V, S\u00e1nchez-Ibarra H, Lozano-Gonzalez K, Villica\u00f1a S, Texis T, Rodr\u00edguez-Dorantes M, Cort\u00e9s-Ram\u00edrez S, Lavalle-Gonzalez F, Sober\u00f3n X, Barrera-Salda\u00f1a H. Transporters, TBC1D4, and ARID5B variants to explain Glycated Hemoglobin variability in patients with type 2 diabetes. Pharmacology. 2021;106(11\u201312):588\u201396.","journal-title":"Pharmacology"},{"issue":"5","key":"2045_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1056-8727(01)00227-6","volume":"16","author":"JM Hempe","year":"2002","unstructured":"Hempe JM, Gomez R, McCarter RJ Jr., Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16(5):313\u201320.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"2045_CR35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/dom.14638","volume":"24","author":"F Gomez-Peralta","year":"2022","unstructured":"Gomez-Peralta F, Choudhary P, Cosson E, Irace C, Rami\u2010Merhar B, Seibold A. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metabolism. 2022;24(4):599\u2013608.","journal-title":"Diabetes Obes Metabolism"},{"issue":"4","key":"2045_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00045415-200107000-00005","volume":"9","author":"KJ Melanson","year":"2001","unstructured":"Melanson KJ, McINNIS KJ, Rippe JM, Blackburn G, Wilson PF. Obesity and cardiovascular disease risk: research update. Cardiol Rev. 2001;9(4):202\u20137.","journal-title":"Cardiol Rev"},{"issue":"3","key":"2045_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jdiacomp.2017.10.007","volume":"32","author":"M Mazidi","year":"2018","unstructured":"Mazidi M, Kengne A-P, Katsiki N, Mikhailidis DP, Banach M. Lipid accumulation product and triglycerides\/glucose index are useful predictors of insulin resistance. J Diabetes Complicat. 2018;32(3):266\u201370.","journal-title":"J Diabetes Complicat"},{"key":"2045_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2018.11.022","volume":"286","author":"P Calabr\u00f2","year":"2019","unstructured":"Calabr\u00f2 P, Niccoli G, Gragnano F, Grove EL, Vergallo R, Mikhailidis DP, Patti G, Spaccarotella C, Katsiki N, Masiero G, et al. Are we ready for a gender-specific approach in interventional cardiology? Int J Cardiol. 2019;286:226\u201333.","journal-title":"Int J Cardiol"},{"key":"2045_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12020-015-0709-4","volume":"50","author":"MI Saad","year":"2015","unstructured":"Saad MI, Abdelkhalek TM, Saleh MM, Kamel MA, Youssef M, Tawfik SH, Dominguez H. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells. Endocrine. 2015;50:537\u201367.","journal-title":"Endocrine"},{"issue":"1","key":"2045_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1751-7176.2010.00386.x","volume":"13","author":"P Deedwania","year":"2011","unstructured":"Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating \u03b2-blockers. J Clin Hypertens. 2011;13(1):52\u20139.","journal-title":"J Clin Hypertens"},{"issue":"4","key":"2045_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.healun.2008.01.012","volume":"27","author":"PF Castro","year":"2008","unstructured":"Castro PF, Miranda R, Verdejo HE, Greig D, Gabrielli LA, Alcaino H, Chiong M, Bustos C, Garcia L, Mellado R. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity. J Heart lung Transplantation. 2008;27(4):435\u201341.","journal-title":"J Heart lung Transplantation"},{"issue":"1","key":"2045_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10741-019-09881-3","volume":"25","author":"C Zuchi","year":"2020","unstructured":"Zuchi C, Tritto I, Carluccio E, Mattei C, Cattadori G, Ambrosio G. Role of endothelial dysfunction in heart failure. Heart Fail Rev. 2020;25(1):21\u201330.","journal-title":"Heart Fail Rev"},{"key":"2045_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","volume":"100","author":"MA Incalza","year":"2018","unstructured":"Incalza MA, D\u2019Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1\u201319.","journal-title":"Vascul Pharmacol"},{"issue":"9","key":"2045_CR44","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.bbagen.2014.05.017","volume":"1840","author":"L Rochette","year":"2014","unstructured":"Rochette L, Zeller M, Cottin Y, Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochim et Biophys Acta (BBA)-General Subj. 2014;1840(9):2709\u201329.","journal-title":"Biochim et Biophys Acta (BBA)-General Subj"},{"issue":"7","key":"2045_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/ars.2007.1631","volume":"9","author":"MR Nicolls","year":"2007","unstructured":"Nicolls MR, Haskins K, Flores SC. Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal. 2007;9(7):879\u201389.","journal-title":"Antioxid Redox Signal"},{"issue":"14","key":"2045_CR46","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02045-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-024-02045-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02045-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T15:08:34Z","timestamp":1708614514000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-024-02045-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1186\/s12944-024-02045-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol for NHANES was approved by the NCHS Research Ethics Review Board, and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}